|
1
|
Sliva D: Suppression of cancer
invasiveness by dietary compounds. Mini Rev Med Chem. 8:677–688.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tanaka R, Kurimoto M, Yoneda M and
Matsunaga S: 17β,21β-Epoxyhopan-3β-ol and β-alnincanol from
Euphorbia supina. Phytochemistry. 29:2253–2256. 1990. View Article : Google Scholar
|
|
3
|
An RB, Kwon JW, Kwon TO, Chung WT, Lee HS
and Kim YC: Chemical constituents from the whole plants of
Euphorbia supina Rafin. Korean J Pharmacognosy. 38:291–295.
2007.
|
|
4
|
Agata I, Hatano T, Nakaya Y, Sugaya T,
Nishibe S, Yoshida T and Okuda T: Tannins and related polyphenols
of euphorbiaceous plants. VIII. Eumaculin A and eusupinin A, and
accompanying polyphenols from Euphorbia maculata L. and E. supina
Rafin. Chem Pharm Bull (Tokyo). 39:881–883. 1991. View Article : Google Scholar
|
|
5
|
Lee SH, Tanaka T, Nonaka G and Nishioka I:
Tannins and related compounds. CV. Monomeric and dimeric
hydrolyzable tannins having a dehydrohexahydroxydiphenoyl group,
supinanin, euphorscopin, euphorhelin and jolkianin, from Euphorbia
species. Chem Pharm Bull (Tokyo). 39:630–638. 1991. View Article : Google Scholar
|
|
6
|
Fang Z, Zeng X, Zhang Y and Zhou G:
Chemical constituents of spotted leaf euphorbia (Euphorbia supina).
Zhongcaoyao. 24:230–233. 1993.
|
|
7
|
Erlund I: Review of the flavonoids
quercetin, hesperetin, and naringenin. Dietary sources,
bioactivities, bioavailability, and epidemiology. Nutr Res.
24:851–874. 2004. View Article : Google Scholar
|
|
8
|
Le Marchand L: Cancer preventive effects
of flavonoids - a review. Biomed Pharmacother. 56:296–301. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu YC, Leung SW, Yeung DK, Hu LH, Chen GH,
Che CM and Man RY: Structure-activity relationships of flavonoids
for vascular relaxation in porcine coronary artery. Phytochemistry.
68:1179–1188. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song Y, Jeong SW, Lee WS, Park S, Kim YH,
Kim GS, Lee SJ, Jin JS, Kim CY, Lee JE, et al: Determination of
polyphenol components of Korean prostrate spurge (Euphorbia supina)
by using liquid chromatography-tandem mass spectrometry: Overall
contribution to antioxidant activity. J Anal Methods Chem.
2014:4186902014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Korean Breast Cancer Society: Korean
breast cancer data of 1996. J Korean Surg Soc. 55:621–635.
1998.
|
|
12
|
Lu X and Kang Y: Hypoxia and
hypoxia-inducible factors: Master regulators of metastasis. Clin
Cancer Res. 16:5928–5935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim HG, Kim GS, Park S, Lee JH, Seo ON,
Lee SJ, Kim JH, Shim JH, Abd El-Aty AM, Jin JS, et al: Flavonoid
profiling in three citrus varieties native to the Republic of Korea
using liquid chromatography coupled with tandem mass spectrometry:
Contribution to overall antioxidant activity. Biomed Chromatogr.
26:464–470. 2012. View
Article : Google Scholar
|
|
14
|
Joo YN, Jin H, Eun SY, Park SW, Chang KC
and Kim HJ: P2Y2R activation by nucleotides released from the
highly metastatic breast cancer cell MDA-MB-231 contributes to
pre-metastatic niche formation by mediating lysyl oxidase
secretion, collagen crosslinking, and monocyte recruitment.
Oncotarget. 5:9322–9334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rucci N, Sanità P and Angelucci A: Roles
of metalloproteases in metastatic niche. Curr Mol Med. 11:609–622.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Przybylowska K, Kluczna A, Zadrozny M,
Krawczyk T, Kulig A, Rykala J, Kolacinska A, Morawiec Z, Drzewoski
J and Blasiak J: Polymorphisms of the promoter regions of matrix
metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Breast
Cancer Res Treat. 95:65–72. 2006. View Article : Google Scholar
|
|
18
|
Zoccoli A, Iuliani M, Pantano F,
Imperatori M, Intagliata S, Vincenzi B, Marchetti P, Papapietro N,
Denaro V, Tonini G, et al: Premetastatic niche: Ready for new
therapeutic interventions? Expert Opin Ther Targets. 16(Suppl 2):
S119–S129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mousa SA: Cell adhesion molecules:
Potential therapeutic and diagnostic implications. Mol Biotechnol.
38:33–40. 2008. View Article : Google Scholar
|
|
20
|
Price JT and Thompson EW: Mechanisms of
tumour invasion and metastasis: Emerging targets for therapy.
Expert Opin Ther Targets. 6:217–233. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Christofori G: New signals from the
invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mitra A, Mishra L and Li S: EMT, CTCs and
CSCs in tumor relapse and drug-resistance. Oncotarget.
6:10697–10711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fox SB, Turner GD, Gatter KC and Harris
AL: The increased expression of adhesion molecules ICAM-3, E- and
P-selectins on breast cancer endothelium. J Pathol. 177:369–376.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nguyen M, Corless CL, Kräling BM, Tran C,
Atha T, Bischoff J and Barsky SH: Vascular expression of E-selectin
is increased in estrogen-receptor-negative breast cancer: A role
for tumor-cell-secreted interleukin-1 alpha. Am J Pathol.
150:1307–1314. 1997.PubMed/NCBI
|
|
27
|
Dejana E, Orsenigo F and Lampugnani MG:
The role of adherens junctions and VE-cadherin in the control of
vascular permeability. J Cell Sci. 121:2115–2122. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Middleton E Jr, Kandaswami C and
Theoharides TC: The effects of plant flavonoids on mammalian cells:
Implications for inflammation, heart disease, and cancer. Pharmacol
Rev. 52:673–751. 2000.PubMed/NCBI
|
|
29
|
Naderi GA, Asgary S, Sarraf-Zadegan N and
Shirvany H: Anti-oxidant effect of flavonoids on the susceptibility
of LDL oxidation. Mol Cell Biochem. 246:193–196. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mamani-Matsuda M, Kauss T, Al-Kharrat A,
Rambert J, Fawaz F, Thiolat D, Moynet D, Coves S, Malvy D and
Mossalayi MD: Therapeutic and preventive properties of quercetin in
experimental arthritis correlate with decreased macrophage
inflammatory mediators. Biochem Pharmacol. 72:1304–1310. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lotito SB and Frei B: Dietary flavonoids
attenuate tumor necrosis factor alpha-induced adhesion molecule
expression in human aortic endothelial cells. Structure-function
relationships and activity after first pass metabolism. J Biol
Chem. 281:37102–37110. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kang TB and Liang NC: Studies on the
inhibitory effects of quercetin on the growth of HL-60 leukemia
cells. Biochem Pharmacol. 54:1013–1018. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Braganhol E, Zamin LL, Canedo AD, Horn F,
Tamajusuku AS, Wink MR, Salbego C and Battastini AM:
Antiproliferative effect of quercetin in the human U138MG glioma
cell line. Anticancer Drugs. 17:663–671. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Indap MA, Radhika S, Motiwale L and Rao
KVK: Quercetin: Antitumor activity and pharmacological
manipulations for increased therapeutic gains. Indian J Pharm Sci.
68:465–469. 2006. View Article : Google Scholar
|
|
35
|
Choi EJ, Bae SM and Ahn WS:
Antiproliferative effects of quercetin through cell cycle arrest
and apoptosis in human breast cancer MDA-MB-453 cells. Arch Pharm
Res. 31:1281–1285. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lin CW, Hou WC, Shen SC, Juan SH, Ko CH,
Wang LM and Chen YC: Quercetin inhibition of tumor invasion via
suppressing PKc delta/ErK/AP-1-dependent matrix metalloproteinase-9
activation in breast carcinoma cells. Carcinogenesis. 29:1807–1815.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Phromnoi K, Yodkeeree S, Anuchapreeda S
and Limtrakul P: Inhibition of MMP-3 activity and invasion of the
MDA-MB-231 human invasive breast carcinoma cell line by
bioflavonoids. Acta Pharmacol Sin. 30:1169–1176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Calderón-Montaño JM, Burgos-Morón E,
Pérez-Guerrero C and López-Lázaro M: A review on the dietary
flavonoid kaempferol. Mini Rev Med Chem. 11:298–344. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Leung HW, Lin CJ, Hour MJ, Yang WH, Wang
MY and Lee HZ: Kaempferol induces apoptosis in human lung non-small
carcinoma cells accompanied by an induction of antioxidant enzymes.
Food Chem Toxicol. 45:2005–2013. 2007. View Article : Google Scholar : PubMed/NCBI
|
